Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Operating Expenses | 44,199 | 38,738 | 31,706 | 24,739 | 20,561 |
| Operating Income | -44,199 | -38,738 | -31,706 | -24,739 | -20,561 |
| Other Income | 35 | 24 | 62 | 117 | 291 |
| Pre-tax Income | -44,164 | -38,714 | -31,644 | -24,622 | -20,270 |
| Net Income Continuous | -44,164 | -38,714 | -31,644 | -24,622 | -20,270 |
| Net Income | $-44,164 | $-38,714 | $-31,644 | $-24,622 | $-20,270 |
| EPS Basic Total Ops | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 |
| EPS Basic Continuous Ops | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 |
| EPS Diluted Total Ops | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 |
| EPS Diluted Continuous Ops | -1.32 | -1.16 | -0.95 | -0.79 | -0.66 |
| EBITDA(a) | $-42,950 | $-37,188 | $-30,838 | $-24,223 | $-20,182 |